Professor Nicholas C W Harvey MA, MB, BChir, PhD, FRCP
Professor of Rheumatology and Clinical Epidemiology, Honorary Consultant Rheumatologist

Professor Nicholas Harvey is Professor of Rheumatology and Clinical Epidemiology within Medicine at the University of Southampton.
Qualifications
1995 - BA (Hons), Physiological Sciences, University of Oxford
1997 - MB BChir, University of Cambridge
2001 - MRCP, Medicine, Royal College of Physicians
2003 - Physiological Sciences, University of Oxford
2007 - PhD, University of Southampton
2008 - CCT, Rheumatology, PMETB
2015 - FRCP, Medicine, Royal College of Physicians
Appointments held
01/08/15 to present
Professor of Rheumatology and Clinical Epidemiology & Honorary Consultant Rheumatologist, Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, University Hospital NHS Trust, Southampton General Hospital, Tremona Road, SOUTHAMPTON SO16 6YD
01/10/2014 - 31/07/2015
Associate Professor in Rheumatology and Clinical Epidemiology, Honorary Consultant Rheumatologist, University Hospital Southampton
01/03/2011 – 30/09/2014
Senior Lecturer, University of Southampton; Honorary Consultant Rheumatologist, University Hospital Southampton
01/08/2008 – 28/02/2011
Senior Clinical Research Fellow, University of Southampton; Honorary Consultant Rheumatologist, University Hospital Southampton
26/02/07 – 01/08/2008
National Institute for Health Research Clinical Lecturer, University of Southampton
10/06 – 10/07
Specialty Registrar Rheumatology, Christchurch Hospital
10/03 – 10/06
Clinical Research Fellow, MRC ERC/UoS
10/02 – 10/03
Specialty Registrar Rheumatology, Southampton General Hospital
10/01 – 10/02
Specialty Registrar Rheumatology, Salisbury District Hospital
Nicholas Harvey is Professor of Rheumatology and Clinical Epidemiology at the MRC Lifecourse Epidemiology Unit, University of Southampton, having originally trained in medicine at the Universities of Oxford and Cambridge. He is Chair of the International Osteoporosis Foundation Committee of Scientific Advisors, a Clinical Trustee of the UK Royal Osteoporosis Society (ROS) and Vice-Chair of the ROS Osteoporosis and Bone Research Academy. He leads an MRC programme focused on the lifecourse epidemiology of bone and joint disease. His work thus incorporates a lifecourse approach to characterisation of the epidemiology and determinants of osteoporotic fracture from cradle to grave, elucidation of underlying mechanisms, and development of novel interventions. He has won many national/international prizes, such as the National Osteoporosis Society Kohn Award and International Osteoporosis Foundation Medal of Achievement. He is an investigator on >£50m grant funding and has published over 225 peer-reviewed papers. He serves the UK and global field as a member of the American Society for Bone and Mineral Research Professional Practice Committee, the UK National Osteoporosis Guideline Group Advisory Committee, Royal Osteoporosis Society (UK) Scientific Programme Committee, Bone Research Society (UK) Committee (2014-2018), UK Biobank Imaging Working Group (leading the DXA assessment of 100,000 individuals), Versus Arthritis Progress Review Committee and NIHR Research for Patient Benefit Regional Advisory Board (2016-2019). He serves as an associate editor for Archives of Public Health, and on the editorial boards of Bone and Osteoporosis International. He reviews regularly for JBMR, Bone, Osteoporosis International, Lancet, BMJ, NEJM, and for funding bodies such as UK Medical Research Council, BBSRC, EPSRC, Wellcome Trust, NIHR and INSERM.